Inspire Medical Systems, Inc. Stock price

Equities

INSP

US4577301090

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
214.8 USD +0.60% Intraday chart for Inspire Medical Systems, Inc. +10.02% +5.58%
Sales 2024 * 782M Sales 2025 * 950M Capitalization 6.51B
Net income 2024 * -9M Net income 2025 * 24M EV / Sales 2024 * 7.62 x
Net cash position 2024 * 550M Net cash position 2025 * 655M EV / Sales 2025 * 6.16 x
P/E ratio 2024 *
-526 x
P/E ratio 2025 *
275 x
Employees 1,011
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.1%
More Fundamentals * Assessed data
Dynamic Chart
Morgan Stanley Initiates Inspire Medical Systems at Overweight Rating With $250 Price Target MT
Transcript : Inspire Medical Systems, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 10:30 AM
UBS Adjusts Inspire Medical Systems Price Target to $265 From $220, Maintains Buy Rating MT
Mizuho Adjusts Price Target on Inspire Medical Systems to $250 From $225, Maintains Buy Rating MT
Inspire Medical Systems Q4 Net Income, Revenue Rise; Reaffirms 2024 Revenue Outlook MT
Transcript : Inspire Medical Systems, Inc., Q4 2023 Earnings Call, Feb 06, 2024
Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Reports Q4 Revenue $192.5M, vs. Street Est of $191.2M MT
Inspire Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inspire Medical Systems, Inc. Reaffirms Revenue Guidance for the Full Year 2024 CI
Inspire Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Inspire Medical Systems Names CEO Timothy P. Herbert as Board Chair MT
Inspire Medical Systems, Inc. Announces Board Retirements CI
Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. from Its Board of Directors, Effective on May 2, 2024 CI
Jefferies Initiates Inspire Medical Systems With Buy Rating, Price Target is $245 MT
Transcript : Inspire Medical Systems, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07:30 AM
More news
1 day+0.60%
1 week+10.02%
Current month+19.97%
1 month+20.93%
3 months+5.38%
6 months+7.19%
Current year+5.58%
More quotes
1 week
196.47
Extreme 196.47
223.40
1 month
177.17
Extreme 177.17
223.40
Current year
163.57
Extreme 163.57
226.38
1 year
123.27
Extreme 123.27
330.00
3 years
123.27
Extreme 123.27
330.00
5 years
40.53
Extreme 40.53
330.00
10 years
22.50
Extreme 22.5
330.00
More quotes
Managers TitleAgeSince
Founder 61 07-10-31
Director of Finance/CFO 56 14-05-15
Chief Tech/Sci/R&D Officer 61 22-07-27
Members of the board TitleAgeSince
Director/Board Member 66 19-07-24
Chairman 84 16-10-31
Director/Board Member 79 07-12-31
More insiders
Date Price Change Volume
24-03-28 214.8 +0.60% 614,184
24-03-27 213.5 +2.51% 397,135
24-03-26 208.3 +1.52% 483,545
24-03-25 205.2 +3.94% 418,043
24-03-22 197.4 +1.11% 387,043

Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT

More quotes
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
214.8 USD
Average target price
250.9 USD
Spread / Average Target
+16.83%
Consensus
  1. Stock
  2. Equities
  3. Stock Inspire Medical Systems, Inc. - Nyse